180 Life Sciences Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by 180 Life Sciences Corp. (NASDAQ: ATNF) on October 29, 2024. The filing announces the scheduling of the Company's 2024 Annual Meeting of Shareholders and establishes deadlines for shareholder proposals and director nominations.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
There are no material financial changes reported in this filing. The primary event is the Board of Directors' determination to hold the 2024 Annual Meeting on December 27, 2024. The Company reserves the right to change the meeting date or the record date prior to the event.
Guidance, Outlook, and Corporate Actions
- Annual Meeting Date: Scheduled for December 27, 2024.
- Record Date: Shareholders of record as of the close of business on October 31, 2024, are entitled to vote.
- Proposal Deadline: Shareholder proposals and director nominations must be received by the close of business on November 8, 2024.
- Submission Address: Proposals must be sent to the Corporate Secretary at 3000 El Camino Real, Bldg. 4, Suite 200, Palo Alto, CA 94306.
- Management: The report was signed by Blair Jordan, Interim Chief Executive Officer.
Key Facts for Investor Verification
- Verify the final date and location of the Annual Meeting in the definitive proxy statement once filed.
- Confirm the record date for voting eligibility, noting the Company's reservation to change it.
- Ensure any shareholder proposals or director nominations are submitted by the November 8, 2024 deadline to be considered timely.
- Review the Company's Bylaws and Rule 14a-8 requirements for specific formatting and content rules for proposals.